| Pulmonary arterial hypertension

WINREVAIR vs Tracleer

Side-by-side clinical, coverage, and cost comparison for pulmonary arterial hypertension.
Deep comparison between: Winrevair vs Tracleer with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.
Safety signalsTracleer has a higher rate of injection site reactions vs Winrevair based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Tracleer but not Winrevair, including UnitedHealthcare
Sign up to reveal the full AI analysis
Winrevair
Tracleer
At A Glance
Subcutaneous
Every 3 weeks
Activin signaling inhibitor
Oral
Twice daily
Endothelin receptor antagonist
Indications
  • Pulmonary arterial hypertension
  • Pulmonary arterial hypertension
Dosing
Pulmonary arterial hypertension Starting dose 0.3 mg/kg subcutaneously every 3 weeks; target dose 0.7 mg/kg subcutaneously every 3 weeks after verifying acceptable hemoglobin and platelet count. Check hemoglobin and platelets before each dose for the first 5 doses or longer if values are unstable.
Pulmonary arterial hypertension Adults and patients >12 years and >40 kg: 62.5 mg orally twice daily for 4 weeks, then 125 mg twice daily; patients >12 years and <=40 kg: 62.5 mg twice daily; pediatric patients <=12 years: weight-based dosing ranging from 16 mg to 64 mg twice daily.
Contraindications
  • Pregnancy
  • Concomitant use with cyclosporine A
  • Concomitant use with glyburide
  • Hypersensitivity to bosentan or any component of the product
Adverse Reactions
Most common (>=10%) Headache, epistaxis, rash, telangiectasia, diarrhea, dizziness, erythema, increased hemoglobin
Serious Erythrocytosis, severe thrombocytopenia (platelet count <50,000/mm3), serious bleeding, intrapulmonary right-to-left shunting
Postmarketing Pericardial effusion
Most common (>=3%) Respiratory tract infection, headache, edema, chest pain, syncope, flushing, hypotension, sinusitis, arthralgia, abnormal serum aminotransferases, palpitations, anemia
Serious Hepatotoxicity, embryo-fetal toxicity, fluid retention, decreased sperm counts, decreases in hemoglobin and hematocrit
Postmarketing Angioedema, unexplained hepatic cirrhosis, liver failure, hypersensitivity/DRESS/anaphylaxis, thrombocytopenia, rash, jaundice, anemia requiring transfusion, neutropenia, leukopenia, nasal congestion, autoimmune hepatitis
Pharmacology
Sotatercept-csrk is an activin signaling inhibitor that binds to activin A and other TGF-beta superfamily ligands, improving the balance between pro-proliferative and anti-proliferative signaling to modulate vascular proliferation in pulmonary arterial hypertension.
Bosentan is a specific and competitive antagonist at endothelin receptor types ETA and ETB, blocking the vasoconstrictive and proliferative effects of endothelin-1, a neurohormone elevated in plasma and lung tissue of patients with PAH.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Winrevair
  • Covered on 5 commercial plans
  • PA (12/12) · Step Therapy (9/12) · Qty limit (9/12)
View full coverage details ›
Tracleer
  • Covered on 5 commercial plans
  • PA (11/12) · Step Therapy (0/12) · Qty limit (11/12)
View full coverage details ›
UnitedHealthcare
Winrevair
  • Covered on 4 commercial plans
  • PA (6/8) · Step Therapy (6/8) · Qty limit (2/8)
View full coverage details ›
Tracleer
  • Covered on 4 commercial plans
  • PA (6/8) · Step Therapy (0/8) · Qty limit (6/8)
View full coverage details ›
Humana
Winrevair
  • Covered on 0 commercial plans
  • PA (3/3) · Step Therapy (0/3) · Qty limit (1/3)
View full coverage details ›
Tracleer
  • Covered on 0 commercial plans
  • PA (3/3) · Step Therapy (1/3) · Qty limit (3/3)
View full coverage details ›
Coverage data sourced from MMIT. Updated monthly.
Savings
$5/fillfill
Merck Access Co-pay Assistance: Winrevair
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
$5/fillfill
Janssen CarePath Oral PAH Savings Program: Tracleer
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
  • Verify eligibility with the payer.
  • Pull the right PA forms directly from the payer.
  • Submit, track & send live updates to your dashboard.
Utilize patient records to autofill forms with our AI in seconds.
Free to start · HIPAA compliant
Next Steps for Your Patient
WinrevairView full Winrevair profile
TracleerView full Tracleer profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.